An experienced neurotech team

Christian Angermayer is an entrepreneur, investor, and film enthusiast. He is the founder of Apeiron Investment Group, his family office, and merchant banking business. Apeiron focuses on investments in biotech, fintech & crypto, and deep tech companies. Apeiron completes deals across the entire lifecycle and balance sheet of a company, from non-listed seed/start-up investments to larger-scale restructuring and special situations deals. Passionate about the arts and film, Christian has (executive) produced 21 feature films including critically acclaimed movies like Filth, Aspern Papers and Hector and the Search for Happiness. He is the largest shareholder of DEAG, one of the largest live entertainment companies in Europe. Christian has a unique art collection centered around the theme “Psychedelics / Entheogens”. With his biotech company ATAI Life Sciences, Christian has the ambitious goal to find cures for various mental health issues like depression, anxiety, addiction, and PTSD by bringing back so-called psychedelics like “magic mushrooms” and DMT into the legal realm as powerful medical treatment. In addition to his entrepreneurial activities, Christian places great value on social, political, and societal commitments. He is a Young Global Leader of the World Economic Forum, a member of the Presidential Advisory Council of His Excellency President Paul Kagame of Rwanda, and a member of the Milken Institute Young Leaders Circle. Christian’s “Angermayer Policy and Innovation Forum” convenes several times a year Head of States, leading politicians, artists, investors, and scientists to discuss crucial topics and issues.

Dr. Tim Sievers is an entrepreneur and investor. He founded the FinTech pioneer Deposit Solutions in 2011. By the time he left his role as CEO 10 years later, the company was working with over 400 banks in 25 countries with more than 25bn USD in AuM and had achieved a “unicorn” valuation. Before founding Deposit Solutions, Tim was trained as an economist at the universities of Oxford, LSE, Toulouse, and Hamburg, and has worked as an investor in private equity. He serves as a Member of the Board at Adraxe and Blackrock Neurotech.

Dr. Solzbacher is co-founder and Chairman of Blackrock Neurotech. He is also a Professor and Chair of the Department of Electrical and Computer Engineering and Director of the Center for Engineering Innovation at the University of Utah. Florian holds adjunct appointments as a Professor in Materials Science and Professor of Biomedical Engineering at the University of Utah. He is a fellow of the American Institute for Medical and Biological Engineers AIMBE and a fellow of the Institute of Electrical and Electronics Engineers IEEE. Prof. Solzbacher received his M.Sc. EE (Dipl.-Ing.) from the Technical University Berlin in 1997 and his Ph.D. (Dr.-Ing.) from the Technical University Ilmenau in 2003. He is co-founder of several companies, including Blackrock Microsystems, Blackrock Neuromed, Blackrock Microsystems Europe, Sentiomed, First Sensor Technology, and several others. He was a board member and Chairman of the German Association for Sensor Technology AMA and of Sensor + Test from 2001 until 2009. Florian was director of the Utah Nanofabrication Laboratory until 2013 and served on a number of company and public/private partnership advisory and reviewer boards in Europe and the US including the DFG German Excellence Initiative, the European Research Council ERC, The Utah Governor’s Science and Technology advisory board and on international conference steering committees such as the NIH/NINDS Neural Interfaces Conference. He was Co-Chair of the 2012 NIH Neural Interfaces Conference and the 2014 COMS Conference for Commercialization of Micro and Nanosystems. He is the author of over 190 journal and conference publications, 5 book chapters, and 16 pending patents.

Marcus is CEO of Blackrock Neurotech. He is on the advisory board of various disruptive technology companies including fin-tech Deposit Solutions (US). Marcus has an MPhil from Oxford University and an MA from St. Andrews. He is an entrepreneur focused on innovative technologies and alternative investment markets. In 1999, Marcus helped set up his first start-up, Mondus, a pioneering e-commerce platform. Subsequently, Marcus founded BBI, which advised technology companies on funding, commercialization, and growth strategies. In 2003, he co-founded one of the leading frontier market asset managers in the Middle East. With Blackrock, he is hoping to improve the patient impact as it relates to the final frontier of the human body – the brain. He is all too aware of the limits of his own body when it comes to riding and hiking up and down the Wasatch mountains, but that does not stop him from trying to push that frontier too.

Marcus is CEO of Blackrock Neurotech. He is on the advisory board of various disruptive technology companies including fin-tech Deposit Solutions (US). Marcus has an MPhil from Oxford University and an MA from St. Andrews. He is an entrepreneur focused on innovative technologies and alternative investment markets. In 1999, Marcus helped set up his first start-up, Mondus, a pioneering e-commerce platform. Subsequently, Marcus founded BBI, which advised technology companies on funding, commercialization, and growth strategies. In 2003, he co-founded one of the leading frontier market asset managers in the Middle East. With Blackrock, he is hoping to improve the patient impact as it relates to the final frontier of the human body – the brain. He is all too aware of the limits of his own body when it comes to riding and hiking up and down the Wasatch mountains, but that does not stop him from trying to push that frontier too.

Thomas is a seasoned financial executive with extensive experience as a Chief Financial Officer across North America, Europe, and Asia. Prior to joining Blackrock in 2024, he served as CFO for several R&D-driven organizations, where he led strategic financial initiatives and delivered impactful results. Holding a PhD/MBA in Finance and a California CPA license, Thomas brings deep expertise in US GAAP accounting, cost management, and liquidity optimization. His strong background in managing shared services, streamlining processes, and enhancing system efficiency has been instrumental in driving operational excellence. Fluent in German, English, French, and Mandarin, Thomas excels at aligning multicultural teams and fostering innovation through new technologies.